Einträge von Burchert, Andreas auf dem Publikationsserver

Kriegsmann, Katharina, Bittrich, Max, Sauer, Sandra, Tietze-Stolley, Carola, Movassaghi, Kamran, Grube, Matthias, Vucinic, Vladan, Wehler, Daniela, Burchert, Andreas, Schmidt-Hieber, Martin, Rank, Andreas, Dürk, Heinz A., Metzner, Bernd, Kimmich, Christoph, Hentrich, Marcus, Kunz, Christian, Hartmann, Frank, Khandanpour, Cyrus, de Wit, Maike, Holtick, Udo, Kiehl, Michael, Stoltefuß, Andrea, Kiani, Alexander, Naumann, Ralph, Scholz, Christian W., Tischler, Hans-Joachim, Görner, Martin, Brand, Franziska, Ehmer, Martin und Kröger, Nicolaus (2023) Mobilization and Hematopoietic Stem Cell Collection in Poor Mobilizing Patients with Lymphoma: Final Results of the German OPTIMOB Study. Transfusion Medicine and Hemotherapy 50 (5), S. 403-416. Volltext nicht vorhanden.

Röllig, Christoph, Serve, Hubert, Noppeney, Richard, Hanoun, Maher, Krug, Utz, Baldus, Claudia D., Brandts, Christian H., Kunzmann, Volker, Einsele, Hermann, Krämer, Alwin, Müller-Tidow, Carsten, Schäfer-Eckart, Kerstin, Neubauer, Andreas, Burchert, Andreas, Giagounidis, Aristoteles, Krause, Stefan W., Mackensen, Andreas, Aulitzky, Walter, Herbst, Regina, Hänel, Mathias, Frickhofen, Norbert, Kullmer, Johannes, Kaiser, Ulrich, Kiani, Alexander, Link, Hartmut, Geer, Thomas, Reichle, Albrecht, Junghanß, Christian, Repp, Roland, Meinhardt, Achim, Dürk, Heinz, Klut, Ina-Maria, Bornhäuser, Martin, Schaich, Markus, Parmentier, Stefani, Görner, Martin, Thiede, Christian, von Bonin, Malte, Platzbecker, Uwe, Schetelig, Johannes, Kramer, Michael, Berdel, Wolfgang E. und Ehninger, Gerhard (2021) Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial. Leukemia 35 (9), S. 2517-2525. Volltext nicht vorhanden.

Michel, Christian, Burchert, Andreas, Hochhaus, Andreas, Saussele, Susanne, Neubauer, Andreas, Lauseker, Michael, Krause, Stefan W., Kolb, Hans-Jochem, Hossfeld, Dieter Kurt, Nerl, Christoph, Baerlocher, Gabriela M., Heim, Dominik, Brümmendorf, Tim H., Fabarius, Alice, Haferlach, Claudia, Schlegelberger, Brigitte, Balleisen, Leopold, Goebeler, Maria-Elisabeth, Hänel, Mathias, Ho, Anthony, Dengler, Jolanta, Falge, Christiane, Möhle, Robert, Kremers, Stephan, Kneba, Michael, Stegelmann, Frank, Köhne, Claus-Henning, Lindemann, Hans-Walter, Waller, Cornelius F., Spiekermann, Karsten, Berdel, Wolfgang E., Müller, Lothar, Edinger, Matthias, Mayer, Jiri, Beelen, Dietrich W., Bentz, Martin, Link, Hartmut, Hertenstein, Bernd, Fuchs, Roland, Wernli, Martin, Schlegel, Frank, Schlag, Rudolf, de Wit, Maike, Trümper, Lorenz, Hebart, Holger, Hahn, Markus, Thomalla, Jörg, Scheid, Christof, Schafhausen, Philippe, Verbeek, Walter, Eckart, Michael J., Gassmann, Winfried, Schenk, Michael, Brossart, Peter, Wündisch, Thomas, Geer, Thomas, Bildat, Stephan, Schäfer, Erhardt, Hasford, Joerg, Hehlmann, Rüdiger und Pfirrmann, Markus (2018) Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV. Haematologica 104 (5), S. 955-962. Volltext nicht vorhanden.

Mathew, Nimitha R., Baumgartner, Francis, Braun, Lukas, O'Sullivan, David, Thomas, Simone , Waterhouse, Miguel, Müller, Tony A., Hanke, Kathrin, Taromi, Sanaz, Apostolova, Petya, Illert, Anna L., Melchinger, Wolfgang, Duquesne, Sandra, Schmitt-Graeff, Annette, Osswald, Lena, Yan, Kai-Li, Weber, Arnim, Tugues, Sonia, Spath, Sabine , Pfeifer, Dietmar, Follo, Marie, Claus, Rainer, Lübbert, Michael, Rummelt, Christoph, Bertz, Hartmut, Wäsch, Ralph, Haag, Johanna, Schmidts, Andrea , Schultheiss, Michael, Bettinger, Dominik, Thimme, Robert, Ullrich, Evelyn , Tanriver, Yakup , Vuong, Giang Lam, Arnold, Renate, Hemmati, Philipp, Wolf, Dominik, Ditschkowski, Markus, Jilg, Cordula, Wilhelm, Konrad, Leiber, Christian, Gerull, Sabine, Halter, Jörg, Lengerke, Claudia , Pabst, Thomas, Schroeder, Thomas, Kobbe, Guido, Rösler, Wolf, Doostkam, Soroush, Meckel, Stephan , Stabla, Kathleen, Metzelder, Stephan K., Halbach, Sebastian , Brummer, Tilman , Hu, Zehan, Dengjel, Joern , Hackanson, Björn, Schmid, Christoph, Holtick, Udo, Scheid, Christof, Spyridonidis, Alexandros, Stölzel, Friedrich, Ordemann, Rainer, Müller, Lutz P., Sicre-de-Fontbrune, Flore, Ihorst, Gabriele, Kuball, Jürgen, Ehlert, Jan E., Feger, Daniel, Wagner, Eva-Maria, Cahn, Jean-Yves, Schnell, Jacqueline, Kuchenbauer, Florian, Bunjes, Donald, Chakraverty, Ronjon , Richardson, Simon , Gill, Saar, Kröger, Nicolaus, Ayuk, Francis, Vago, Luca , Ciceri, Fabio, Müller, Antonia M., Kondo, Takeshi , Teshima, Takanori, Klaeger, Susan, Kuster, Bernhard, Kim, Dennis (Dong Hwan), Weisdorf, Daniel, van der Velden, Walter, Dörfel, Daniela, Bethge, Wolfgang, Hilgendorf, Inken, Hochhaus, Andreas, Andrieux, Geoffroy, Börries, Melanie, Busch, Hauke , Magenau, John, Reddy, Pavan, Labopin, Myriam, Antin, Joseph H., Henden, Andrea S. , Hill, Geoffrey R., Kennedy, Glen A., Bar, Merav, Sarma, Anita, McLornan, Donal, Mufti, Ghulam, Oran, Betul, Rezvani, Katayoun, Shah, Omid, Negrin, Robert S., Nagler, Arnon, Prinz, Marco, Burchert, Andreas, Neubauer, Andreas, Beelen, Dietrich, Mackensen, Andreas, von Bubnoff, Nikolas, Herr, Wolfgang, Becher, Burkhard, Socié, Gerard, Caligiuri, Michael A., Ruggiero, Eliana, Bonini, Chiara, Häcker, Georg, Duyster, Justus, Finke, Jürgen, Pearce, Erika, Blazar, Bruce R. und Zeiser, Robert (2018) Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells. Nature Medicine 24 (3), S. 282-291. Volltext nicht vorhanden.

Röllig, Christoph, Serve, Hubert , Hüttmann, Andreas, Noppeney, Richard, Müller-Tidow, Carsten, Krug, Utz, Baldus, Claudia D, Brandts, Christian H , Kunzmann, Volker, Einsele, Hermann, Krämer, Alwin, Schäfer-Eckart, Kerstin, Neubauer, Andreas, Burchert, Andreas, Giagounidis, Aristoteles, Krause, Stefan W , Mackensen, Andreas, Aulitzky, Walter, Herbst, Regina, Hänel, Mathias, Kiani, Alexander, Frickhofen, Norbert, Kullmer, Johannes, Kaiser, Ulrich, Link, Hartmut, Geer, Thomas, Reichle, Albert, Junghanß, Christian, Repp, Roland, Heits, Frank, Dürk, Heinz, Hase, Jana, Klut, Ina-Maria, Illmer, Thomas, Bornhäuser, Martin, Schaich, Markus, Parmentier, Stefani, Görner, Martin, Thiede, Christian , von Bonin, Malte, Schetelig, Johannes, Kramer, Michael, Berdel, Wolfgang E und Ehninger, Gerhard (2015) Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial. The Lancet Oncology 16 (16), S. 1691-1699. Volltext nicht vorhanden.

Fabarius, Alice, Kalmanti, Lida, Dietz, Christian T., Lauseker, Michael , Rinaldetti, Sébastien, Haferlach, Claudia, Göhring, Gudrun, Schlegelberger, Brigitte, Jotterand, Martine, Hanfstein, Benjamin, Seifarth, Wolfgang, Hänel, Mathias, Köhne, Claus-Henning, Lindemann, Hans W., Berdel, Wolfgang E., Staib, Peter, Müller, Martin C., Proetel, Ulrike, Balleisen, Leopold, Goebeler, Maria-Elisabeth, Dengler, Jolanta, Falge, Christiane, Kanz, Lothar, Burchert, Andreas, Kneba, Michael, Stegelmann, Frank, Pfreundschuh, Michael, Waller, Cornelius F., Spiekermann, Karsten, Brümmendorf, Tim H., Edinger, Matthias , Hofmann, Wolf-Karsten, Pfirrmann, Markus, Hasford, Joerg, Krause, Stefan , Hochhaus, Andreas , Saußele, Susanne und Hehlmann, Rüdiger (2015) Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML. Annals of Hematology 94 (12), S. 2015-2024. Volltext nicht vorhanden.

Bornhäuser, Martin, Kienast, Joachim, Trenschel, Rudolf, Burchert, Andreas, Hegenbart, Ute, Stadler, Michael, Baurmann, Herrad, Schäfer-Eckart, Kerstin, Holler, Ernst, Kröger, Nicolaus, Schmid, Christoph, Einsele, Herrmann, Kiehl, Michael G, Hiddemann, Wolfgang, Schwerdtfeger, Rainer, Buchholz, Stefanie, Dreger, Peter, Neubauer, Andreas, Berdel, Wolfgang E, Ehninger, Gerhard, Beelen, Dietrich W, Schetelig, Johannes und Stelljes, Matthias (2012) Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial. The Lancet Oncology 13 (10), S. 1035-1044. Volltext nicht vorhanden.

Bornhauser, Martin, Kienast, Joachim, Trenschel, Rudolf, Burchert, Andreas, Hegenbart, Ute, Stadler, Michael, Baurmann, Herrad, Schäfer-Eckart, K., Holler, Ernst, Kröger, Nicolaus, Schmid, Christoph, Einsele, Hermann, Kiehl, Michael, Schwerdtfeger, Rainer, Ganser, Arnold, Dreger, Peter, Neubauer, Andreas, Berdel, Wolfgang E., Ehninger, Gerhard, Beelen, Dietrich, Schetelig, Johannes und Stelljes, Matthias (2011) An Intergroup Randomised Trial of Standard Intensity Versus Reduced Intensity TBI-Based Conditioning In Patients with Acute Myeloid Leukemia in First Complete Remission. Blood 118 (21), S. 157. Volltext nicht vorhanden.

Alchalby, Haefaa, Zabelina, Tatjana, Wolff, Daniel, Kobbe, Guido, Bornhäuser, Martin, Baurmann, Herrad, Nagler, Arnon, Bethge, Wolfgang A., Stelljes, Matthias, Uharek, Lutz, Schaefer-Eckert, Kerstin, Burchert, Andreas, Corradini, Paolo, Schubert, Joerg E. A., Kaufmann, Martin, Dreger, Peter, Wulf, Gerald, Stuhler, Gernot, Kvasnicka, Hans-Michael , Zander, Axel R., Niederwieser, Dietger, Brand, Ronald, de Witte, Theo M. und Kröger, Nicolaus (2011) Long Term Follow-up of the Prospective Multicenter Study of reduced-Intensity Allogeneic Stem Cell Transplantation for Primary or Post ET/PV Myelofibrosis. Blood 118 (21), S. 1019. Volltext nicht vorhanden.

Kröger, Nicolaus, Holler, Ernst, Kobbe, Guido, Bornhäuser, Martin, Schwerdtfeger, Rainer, Baurmann, Herrad, Nagler, Arnon, Bethge, Wolfgang, Stelljes, Matthias, Uharek, Lutz, Wandt, Hannes, Burchert, Andreas, Corradini, Paolo , Schubert, Jörg, Kaufmann, Martin, Dreger, Peter, Wulf, Gerald G., Einsele, Hermann, Zabelina, Tatjana, Kvasnicka, Hans Michael , Thiele, Jürgen, Brand, Ronald, Zander, Axel R., Niederwieser, Dietger und de Witte, Theo M. (2009) Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Blood 114 (26), S. 5264-5270. Volltext nicht vorhanden.

Kroeger, Nicolaus, Holler, Ernst, Kobbe, Guido, Bornhaeuser, Martin, Schwerdtfeger, Rainer, Nagler, Arnon, Bethge, Wolfgang, Stelljes, Matthias, Uharek, Lutz, Wandt, Hannes, van Os, Marleen, Burchert, Andreas, Corradini, Paolo, Schubert, Joerg, Kaufmann, Martin, Dreger, Peter, Wulf, Gerald, Einsele, Hermann, Gramatzki, Martin, Zabelina, Tatjana, Bacher, Ulrike, Zander, Axel, Heinzelmann, Marion, Kvasnicka, Michael, Thiele, Juergen, Niederwieser, Dietger und de Witte, Theo (2007) Dose-Reduced Conditioning Followed by Allogeneic Stem Cell Transplantation in Patients with Myelofibrosis. Results from a Multicenter Prospective Trial of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Blood 110 (11), S. 683. Volltext nicht vorhanden.